TickerFacts.

A business in context

GMED research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-18 · 0001193125-26-357121

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-054450

  3. 8-K · Current report

    Report date 2026-08-06 · 0001628280-26-054353 · Items 2.02,9.01

  4. 4 · Ownership change

    Report date 2026-07-27 · 0001193125-26-321442

  5. 4 · Ownership change

    Report date 2026-06-05 · 0001193125-26-263997

  6. 4 · Ownership change

    Report date 2026-06-04 · 0001193125-26-262067

  7. 8-K · Current report

    Report date 2026-06-03 · 0001628280-26-040784 · Items 5.02,5.07,9.01

  8. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-032290

  9. 8-K · Current report

    Report date 2026-05-07 · 0001628280-26-032164 · Items 2.02,9.01

  10. DEF 14A · Proxy statement

    Report date 2026-06-03 · 0001628280-26-027196

  11. 8-K · Current report

    Report date 2026-03-23 · 0001628280-26-020612 · Items 5.02,7.01,9.01

  12. 4 · Ownership change

    Report date 2026-02-25 · 0001193125-26-083348

  13. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-011209

  14. 8-K · Current report

    Report date 2026-02-24 · 0001628280-26-011124 · Items 2.02,9.01

  15. 4 · Ownership change

    Report date 2026-02-12 · 0001193125-26-055137

  16. 4 · Ownership change

    Report date 2026-01-21 · 0001193125-26-021266

  17. 4 · Ownership change

    Report date 2026-01-21 · 0001193125-26-021263

  18. 8-K · Current report

    Report date 2026-01-07 · 0001628280-26-001189 · Items 2.02,9.01

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001237831-25-000031

  20. 8-K · Current report

    Report date 2025-11-06 · 0001237831-25-000029 · Items 2.02,9.01

  21. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001562762-25-000200

  22. 8-K · Current report

    Report date 2025-08-07 · 0001562762-25-000198 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-07-18 · 0001562762-25-000166 · Items 2.02,5.02,7.01,9.01

  24. 8-K · Current report

    Report date 2025-06-04 · 0001562762-25-000158 · Items 5.02,5.07,9.01

  25. 8-K · Current report

    Report date 2025-05-15 · 0001562762-25-000131 · Items 8.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001562762-25-000118

  27. 8-K · Current report

    Report date 2025-05-08 · 0001562762-25-000114 · Items 2.02,9.01

  28. DEF 14A · Proxy statement

    Report date 2025-06-04 · 0001562762-25-000092

  29. 8-K · Current report

    Report date 2025-04-03 · 0001193125-25-071923 · Items 2.01,7.01,9.01

  30. 10-K · Annual report

    Report date 2024-12-31 · 0001562762-25-000026

  31. 8-K · Current report

    Report date 2025-02-20 · 0001562762-25-000024 · Items 2.02,9.01

  32. 8-K · Current report

    Report date 2025-02-06 · 0001193125-25-021848 · Items 1.01,7.01,8.01,9.01

  33. 8-K · Current report

    Report date 2025-01-08 · 0001562762-25-000006 · Items 2.02,9.01

  34. SC 13G/A · Ownership disclosure

    0001274173-24-000135

  35. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001562762-24-000254

  36. 8-K · Current report

    Report date 2024-11-05 · 0001562762-24-000250 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2024-07-16 · 0001562762-24-000209 · Items 8.01

  38. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001562762-24-000199

  39. 8-K · Current report

    Report date 2024-08-06 · 0001562762-24-000195 · Items 2.02,9.01

  40. 8-K · Current report

    Report date 2024-06-05 · 0001562762-24-000163 · Items 5.02,5.07,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 0 transaction rows0AExercise / conversion: 4 transaction rows4MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

5 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-05
2026-06-09
Davidar David DM · Exercise / conversion
Acquired
Class A Common Stock25000.026.27
2026-06-05
2026-06-09
Davidar David DS · Sale
Disposed
Class A Common Stock25000.080.76
2026-06-05
2026-06-09
Davidar David DM · Exercise / conversion
Disposed
Stock Option (Right to Buy Class A Common Stock)
Derivative security
25000.00.0
2026-06-04
2026-06-08
RHOADS ANN DM · Exercise / conversion
Acquired
Class A Common Stock25000.026.27
2026-06-04
2026-06-08
RHOADS ANN DM · Exercise / conversion
Disposed
Stock Option (Right to Buy Class A Common Stock)
Derivative security
25000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001237831GLOBUS MEDICAL INC

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
5299003M2P4CIK0RF205
GLEIF legal name
GLOBUS MEDICAL, INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-01-22T18:36:02Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Globus Medical · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$2.52B$2.68B
2023-12-31$1.57B$1.72B
2022-12-31$1.02B$1.17B
2021-12-31$958.10M$1.18B
2020-12-31$789.04M$1.02B
2019-12-31$785.37M$1.03B
2018-12-31$712.97M$948.06M
2017-12-31$635.98M$866.35M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗